News
12 Health Care Stocks Moving In Monday's After-Market Session
27 May 24
Movers
12 Health Care Stocks Moving In Friday's After-Market Session
10 May 24
Movers
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
8 May 24
News
12 Health Care Stocks Moving In Friday's Pre-Market Session
3 May 24
Movers
Alterity Therapeutics Announced Presentation Of New Data Demonstrating Potential Of ATH434 To Treat Rare Neurodegenerative Disease Friedreich's Ataxia
28 Apr 24
News
12 Health Care Stocks Moving In Wednesday's Intraday Session
24 Apr 24
Movers
Alterity Therapeutics Parkinson's Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
17 Apr 24
News
12 Health Care Stocks Moving In Monday's After-Market Session
15 Apr 24
Movers
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
15 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Monday's Intraday Session
15 Apr 24
Movers
12 Health Care Stocks Moving In Monday's Pre-Market Session
15 Apr 24
Movers
Press releases
Alterity Therapeutics to Present at the MST Access 'Hidden Gems in Life Sciences' Webinar
12 Jun 24
News, Press Releases
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
29 May 24
News, Press Releases
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
8 May 24
Health Care, Press Releases
Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
30 Apr 24
Press Releases
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich's Ataxia
29 Apr 24
Press Releases
Alterity Therapeutics Parkinson's Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
17 Apr 24
News, Health Care, Press Releases
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
10 Apr 24
News, Press Releases
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
26 Mar 24
News, Financing, Press Releases